Lumiwell-AT Injection
Marketer
Wellmark Lifesciences Private Limited
Salt Composition
Artesunate (60mg)
Overview Lumiwell-AT Injection
Malarex injection combats parasitic infections, specifically treating malaria. However, it's unsuitable for malaria prevention or severe cases involving neurological, pulmonary, or renal compromise. Administration requires a healthcare provider; self-injection is strictly prohibited. Intravenous administration is reserved for situations precluding oral intake. Common side effects include headache, vertigo, fatigue, and anorexia. Injection site reactions such as soreness, edema, or erythema may also occur. Persistent symptoms warrant immediate medical attention. Post-treatment, weekly blood tests for four weeks may be conducted to monitor parasite levels.
Uses of Lumiwell-AT Injection
Plasmodium infection
Major Benefits of Lumiwell-AT Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Lumiwell-AT Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Lumiwell-AT Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Lumiwell-AT Injection works:
Lumiwell-AT Injection is an antiparasitic drug that eliminates malarial parasites by generating intracellular free radicals, leading to parasite death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lumiwell-AT Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Lumiwell-AT Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Lumiwell-AT Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant harm from the medication.
DrivingUNSAFE
Administration of Lumiwell-AT Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lumiwell-AT Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Lumiwell-AT Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lumiwell-AT Injection :
Omit a Lumiwell-AT Injection dose? Seek your physician's advice.
Facts to Know About Lumiwell-AT Injection
| Label | Value |
|---|---|
| Chemical Category | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
| Behavior Class | Artemisinin-based antimalarials |
3,018 People bought this recently